DBV Technologies | DBVT - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amarin USD 20.81M 13K 2025-12
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
DBV Technologies USD 235.6M 98.78M 2025-12
Galectin Therapeutics USD 61K 0 2023-12
Halozyme Therapeutics USD 114.04M 4.48M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Insmed USD 218.28M 1.76M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Neurocrine Biosciences USD 100.55M 50K 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Sarepta Therapeutics USD 105.62M 53K 2026-06
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
United Therapeutics USD 42.68M 521K 2026-06